# Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)

> **NCT00951964** · PHASE2 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 18 (actual)

## Conditions studied

- Epidermolysis Bullosa Dystrophica

## Interventions

- **DRUG:** Polyphenon E before Placebo
- **DRUG:** placebo before treatment

## Key facts

- **NCT ID:** NCT00951964
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951964, "Treatment of Epidermolysis Bullosa Dystrophica by Polyphenon E (Epigallocatechin 3 Gallate)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00951964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*